Respiratory Distress Syndrome
25 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Lung Diseases, Respiration Disorders
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| a wake prone positioning for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Apremilast for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Atibuclimab for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Aviptadil for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Awake prone positioning for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cenicriviroc for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cyclosporine for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cyproheptadine for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dornase alfa for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| EIT-Group for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Famotidine + Celecoxib for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hydroxychloroquine for respiratory distress syndrome | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hydroxychloroquine Pill + Azithromycin Pill for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ibuprofen for respiratory distress syndrome | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Icatibant for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Imatinib Mesylate for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| LEAF-4L6715 for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Narsoplimab for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Prone decubitus for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Prone Position for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| prone positioning for respiratory distress syndrome | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Prone Positioning (PP) for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Solizmestrocel for respiratory distress syndrome | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| UC-MSC and Secretome for respiratory distress syndrome | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Wharton's jelly derived Mesenchymal stem cells. for respiratory distress syndrome | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.